You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Synthon Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SYNTHON PHARMS, and what generic and branded alternatives to SYNTHON PHARMS drugs are available?

SYNTHON PHARMS has fifteen approved drugs.

There are three tentative approvals on SYNTHON PHARMS drugs.

Summary for Synthon Pharms

US Patents:	0
Tradenames:	12
Ingredients:	12
NDAs:	15

Drugs and US Patents for Synthon Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Synthon Pharms	SIMVASTATIN	simvastatin	TABLET, ORALLY DISINTEGRATING;ORAL	021961-004	Oct 9, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Synthon Pharms	SIMVASTATIN	simvastatin	TABLET, ORALLY DISINTEGRATING;ORAL	021961-003	Oct 9, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET, ORALLY DISINTEGRATING;ORAL	022026-003	Sep 27, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Synthon Pharms	SIMVASTATIN	simvastatin	TABLET, ORALLY DISINTEGRATING;ORAL	021961-002	Oct 9, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Synthon Pharms	ZOLPIDEM TARTRATE	zolpidem tartrate	TABLET, EXTENDED RELEASE;ORAL	078483-001	Apr 12, 2011		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Synthon Pharms	LETROZOLE	letrozole	TABLET;ORAL	090196-001	Jun 3, 2011		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Synthon Pharms	RISPERIDONE	risperidone	TABLET;ORAL	078187-002	Oct 22, 2009		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Synthon Pharms

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET, ORALLY DISINTEGRATING;ORAL	022026-001	Sep 27, 2007	6,828,339	⤷ Sign Up
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET, ORALLY DISINTEGRATING;ORAL	022026-003	Sep 27, 2007	6,828,339	⤷ Sign Up
Synthon Pharms	AMLODIPINE BESYLATE	amlodipine besylate	TABLET, ORALLY DISINTEGRATING;ORAL	022026-002	Sep 27, 2007	6,828,339	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.